Immunome
IMNM
19.10
-0.22
-1.11%
Immunome
US · IMNM
#2671 by market cap
Listed 2020
19.10
-0.22
-1.11%
Live - 5344 symbols - heartbeat 241s ago
· 2026-10-08 06:54
Pre-market
19.00
-0.50%
After-hours
19.10
0.00%
- Market cap
- 2.25B
- P/E (TTM)i
- -7.55
- P/Bi
- 4.29
- EPSi
- -2.43
- Div yieldi
- 0.00%
- 52W posi
- 34%
Reader sentiment
Are you bullish or bearish on IMNM?
Anonymous reader poll. Unscientific, not investment advice.
About Immunome
Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas. The company was founded by Scott K. Dessain and Gregory P. Licholai on March 2, 2006 and is headquartered in Bothell, WA.
- Founded
- 2006
- CEO
- Dr. Clay B. Siegall,PhD
- Employees
- 177
- Headquarters
- Bothell, Washington, United States of America
- Fiscal year end
- 12-31
- Website
- immunome.com
Company profile
- Exchange
- US
- Symbol
- IMNM
- Market-cap rank
- #2671
- Listing date
- 2020-10-02
- Market cap
- 2.25B
- Float cap
- 2.16B
- Shares out
- 118.00M
- Float shares
- 113.08M
Sectors & themes
Biotechnology
Fractional Shares JP
Quote time 2026-10-08 06:54:41 · For reference only, not investment advice and not tailored to your situation.